secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2023-05-17T23:59:59+00:00
Accession:  0001493152-23-017946
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Abeona shareholders elect directors, approve 2023 equity plan at annual meeting
-------------------------------------------------------------------------------

- Michael Amoroso (6.5M for) and Christine Silverstein (6.2M for) elected Class I directors until 2026.
- Abeona Therapeutics 2023 Equity Incentive Plan approved: 6.2M for, 569K against, 18K abstentions.
- Advisory vote on named executive officer compensation passed: 6.4M for, 282K against, 37K abstentions.
- Ratification of Whitley Penn LLP as independent auditor for FY2023 passed: 10.4M for, 49K against, 28K abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315223017946/0001493152-23-017946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315223017946/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-017946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer